Weiss A, Lackman R
THOMAS JEFFERSON UNIV,SCH MED,DEPT MED,PHILADELPHIA,PA 19107. THOMAS JEFFERSON UNIV,SCH MED,DEPT ORTHOPED SURG,PHILADELPHIA,PA 19107.
Int J Oncol. 1995 Oct;7(4):773-6. doi: 10.3892/ijo.7.4.773.
Forty-seven patients with unresectable desmoid tumors and 32 patients with unresectable fibromatosis were treated with various anti-neoplastic agents including methotrexate, vinblastine, etoposide, actinomycin D, and fluorouracil. A combination of methotrexate with either vinblastine or etoposide was found to be effective in yielding long-term control to both groups of patients. Fluorouracil and actinomycin D were less effective. Other than a significant but slowly reversible peripheral neuropathy in 6 patients, therapy was well tolerated and no long-term hematologic, pulmonary, hepatic, or cardiac toxicity was noted in any patient.
47例不可切除的硬纤维瘤患者和32例不可切除的纤维瘤病患者接受了包括甲氨蝶呤、长春碱、依托泊苷、放线菌素D和氟尿嘧啶在内的多种抗肿瘤药物治疗。发现甲氨蝶呤与长春碱或依托泊苷联合使用对两组患者均能有效实现长期控制。氟尿嘧啶和放线菌素D效果较差。除6例患者出现显著但可逆性缓慢的周围神经病变外,治疗耐受性良好,未观察到任何患者出现长期血液学、肺部、肝脏或心脏毒性。